Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Pre-admission anti-coagulation does not improve all-cause mortality in geriatric COVID-19 patients

Flora Olcott, Clare Hunt, Terrence Chan and George Williams
Download PDF
DOI: https://doi.org/10.7861/clinmed.21-2-s7
Clin Med March 2021
Flora Olcott
ADartford and Gravesham NHS Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Hunt
ADartford and Gravesham NHS Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terrence Chan
ADartford and Gravesham NHS Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Williams
BBarts Health NHS Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Introduction

Initial studies have shown that patients infected with SARS-CoV-2 are at high risk of venous-thromboembolic events (VTE).1 Post-mortem studies of patients with COVID-19 disease frequently show diffuse alveolar damage, pulmonary emboli and microthrombi in the lungs.2 Derangement of coagulation parameters such as a significantly raised D-dimer, fibrinogen and prolonged prothrombin time has also been observed and often is prognostically important with regard to mortality.3 Rapid advances have been made in establishing treatments for COVID-19, including anticoagulation therapies. This retrospective observational study investigates whether pre-admission anticoagulation with warfarin or a direct oral anticoagulant (DOAC) improves all-cause mortality for geriatric COVID-19 patients compared to those who are not anticoagulated before admission.

Materials and methods

A total of 309 patients aged 70 and over who were admitted to a district general hospital in south-east England between 15 March and 31 May 2020 were included. Infection with SARS-CoV-2 was confirmed with viral PCR testing during that admission. Preadmission anticoagulant therapy was ascertained by looking at the medications section of the most recent hospital discharge letter on electronic records. The outcome of patients was classified as either discharge or death.

Results and discussion

161 male patients (52.1%) and 148 female patients (47.9%) were included, with median age for discharged patients being 83 (range 70–101) and 85 (range 70–105) being the median age of those who died.

A total of 26.2% (n=81) were prescribed oral anticoagulation prior to admission; 69 were on a DOAC and 12 on warfarin (Fig 1). Of those who were anticoagulated, 46.9% (n=38) died during admission, compared to 48.2% (n=110) among those without pre-admission anticoagulation (Fig 2). There was no statistically significant improvement in all-cause mortality for patients who were anticoagulated preadmission on univariate analysis (odds ratio (OR) 0.95; 95% confidence interval (CI) 0.56–1.57; p>0.05).

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Proportion of patients on pre-admission anti-coagulation vs not on anticoagulation.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Outcome for patients on pre-admission anti-coagulation vs not on anticoagulation.

Proportionally more male patients with COVID-19 died during admission compared to females (57% vs 43%; p=0.021). While not statistically significant, male patients with SARS-CoV-2 infection were found to have a higher mortality compared to female patients (OR 1.47; 95% CI 0.94–2.30; p=0.094).

Limitations

Due to lack of electronic prescribing at the hospital, drug history was taken from the medications list in previous discharge letters. Some patients may have commenced anticoagulation therapy in primary care or other secondary/tertiary care institutions. Conversely, some of the patients recorded as anticoagulated may have stopped taking the medication prior to the admission studied here. We did not assess compliance, type of DOAC or dosage, which may have impacted the results.

Conclusion

Pre-admission anticoagulation therapy does not appear to improve all-cause mortality for elderly patients admitted to hospital with COVID-19, suggesting that patients on anticoagulation therapy have the same mortality rate as those who are not taking these agents. Larger sample size, correlation of mortality with coagulation parameters and comparison with younger age groups with COVID-19 would be useful to examine to gain more understanding of how this disease affects the older generation and to potentially advance treatments.

Conflicts of interest

None declared.

  • © Royal College of Physicians 2021. All rights reserved.

References

  1. ↵
    1. Middeldorp S
    , Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 2020;18:1995–2002.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Deshpande C
    . Thromboembolic findings in COVID-19 autopsies: pulmonary thrombosis or embolism? Ann Intern Med 2020;173:394–5.
    OpenUrl
  3. ↵
    1. Yao Y
    , Cao J, Wang Q, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care 2020;8:49.
    OpenUrl
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Pre-admission anti-coagulation does not improve all-cause mortality in geriatric COVID-19 patients
Flora Olcott, Clare Hunt, Terrence Chan, George Williams
Clinical Medicine Mar 2021, 21 (Suppl 2) 7-8; DOI: 10.7861/clinmed.21-2-s7

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pre-admission anti-coagulation does not improve all-cause mortality in geriatric COVID-19 patients
Flora Olcott, Clare Hunt, Terrence Chan, George Williams
Clinical Medicine Mar 2021, 21 (Suppl 2) 7-8; DOI: 10.7861/clinmed.21-2-s7
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Materials and methods
    • Results and discussion
    • Limitations
    • Conclusion
    • Conflicts of interest
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Improving transthoracic echocardiography (TTE) training for junior doctors in Harefield Hospital during COVID-19
  • The impact of COVID-19 telephone consultations on renal clinic non-attendance
  • Simulation via instant messaging – Birmingham advance (SIMBA): an innovative simulation-based learning model that helped to keep medical education continue during the COVID-19 pandemic
Show more COVID-19

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians